Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on high selectivity. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a cost-effective, high-yield synthesis for Sacubitril intermediates with >99% purity and >98% ee, eliminating isomer impurities and supply chain risks.
Discover how this novel chiral catalyst enables 99% ee synthesis with 90% yield, reducing R&D costs and supply chain risks for oncology drug development.
Discover how novel biphenyl-type tridentate ligand ruthenium complexes enable ester-to-alcohol hydrogenation at 60-100°C and 3-10MPa, reducing costs and safety risks for pharma production.
Discover a scalable, cost-effective synthesis method for indolocyclopentane compounds with >95% yield and 93% ee. Ideal for pharmaceutical R&D and production of prostate cancer therapeutics.
Discover N-N axis chiral indole-pyrrole synthesis with 97% ee, reducing R&D costs and supply chain risks for asymmetric pharmaceutical catalysts.
Discover a novel indolocyclopentane synthesis method with >95% yield and 93% ee. Ideal for pharmaceutical R&D targeting PC-3 prostate cancer cells. Scale up with CDMO expertise.
Discover how this novel asymmetric catalytic hydrogenation method enables high-yield, high-ee synthesis of chiral dihydro-9-phenanthrene amine for pharmaceutical applications.
Discover how this novel axial chiral phosphine catalyst enables high-yield, high-enantioselective synthesis for pharmaceutical intermediates, reducing production costs and supply chain risks.
Discover the breakthrough in spirooxindole synthesis with high yield and anti-tumor activity. Optimize your drug development process with this efficient method.
Discover how N-heterocyclic carbine catalysis enables high-yield, enantioselective synthesis of spiro hydroxyindole pentamethylene beta-lactones for drug development and insecticide production.
Discover high-purity axial chiral cyclopentenyl indole-naphthyl compounds with 99% ee for PC-3 cancer cell cytotoxicity. Optimize your drug development with scalable synthesis.
Solve chiral amine synthesis challenges with 99% ee, 1% catalyst loading, and gram-scale production for drug development
Discover a novel, high-yield synthesis method for E-type benzofulvene derivatives with exceptional stereoselectivity and scalable production for your pharmaceutical R&D and manufacturing needs.
Discover a breakthrough chiral rhodium-catalyzed method for carbon-nitrogen axial chiral indole-naphthol compounds with 96%ee, mild conditions, and high yield. Reduce R&D costs and supply chain risks for your API synthesis.
Discover a scalable, high-yield synthesis of E-type benzofulvene derivatives with excellent stereoselectivity. Reduce production costs and supply chain risks for your pharmaceutical intermediates.
Struggling with low enantioselectivity in axial chiral indole synthesis? Discover emerging catalytic methods for high-purity compounds with 98:2 er. Find reliable suppliers for pharma R&D.